Service profile
Marker Therapeutics
Clinical-stage immuno-oncology company developing multi-tumor antigen-specific T cell therapies for hematological malignancies and solid tumors using its MultiTAA platform technology.
About
What Marker Therapeutics is
Clinical-stage immuno-oncology company developing multi-tumor antigen-specific T cell therapies for hematological malignancies and solid tumors using its MultiTAA platform technology.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://markertherapeutics.com |
| Status coverage | Public status page |
| Founded | 1991 |
| Headquarters | Houston, Texas, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...